Methods of treating multiple sclerosis using STRO-1+ and TNAP+ multipotential cells
US10206951B2 · kind B2 · utility
1Cited by
7References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 4, 2012 |
| Grant date | Feb 19, 2019 |
| Priority date | — |
| Expiry date | Jun 4, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides a method for treating an inflammatory neurological disease comprising administering a population of cells enriched for STRO-1+ cells and/or progeny thereof and/or soluble factors derived therefrom.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.